BioDelivery Sciences International, Inc.
NASDAQ: BDSI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Herm Cukier
- Employees
- 200
- Headquarters
- Raleigh, United States
- IPO year
- 2002
- Market cap
- $577.1M
- Website
- https://www.bdsi.com
Loading BDSI…
Loading profile data…Frequently asked questions about BDSI
What does BioDelivery Sciences International, Inc. (BDSI) do?
BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical firm dedicated to the advancement and commercialization of therapeutic products designed for long-term health conditions, serving markets both within the United States and internationally. The company's product offerings leverage its proprietary BioErodible MucoAdhes...
Where does BDSI trade?
BioDelivery Sciences International, Inc. (BDSI) trades on the NASDAQ Global Select.
What sector is BDSI in?
BioDelivery Sciences International, Inc. (BDSI) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of BioDelivery Sciences International, Inc.?
Herm Cukier is the chief executive officer of BioDelivery Sciences International, Inc. (BDSI).
Where is BioDelivery Sciences International, Inc. headquartered?
BioDelivery Sciences International, Inc. is headquartered in United States.
Does BDSI pay a dividend?
BioDelivery Sciences International, Inc. (BDSI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BDSI go public?
BioDelivery Sciences International, Inc. (BDSI) completed its initial public offering in 2002.